Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Pulmonary Hypertension

  Free Subscription


1 Am J Cardiol
1 Am J Transplant
1 Animals (Basel)
1 Basic Clin Pharmacol Toxicol
1 Biomed Pharmacother
1 BMJ Case Rep
1 Cardiovasc Res
2 Chest
1 Circulation
1 Clin Genet
1 Clin Nucl Med
1 Clin Rheumatol
1 Cold Spring Harb Mol Case Stud
1 Commun Biol
1 Comput Biol Med
3 Cureus
2 Curr Probl Cardiol
1 ESC Heart Fail
1 Eur Respir J
1 Expert Opin Pharmacother
1 Front Cardiovasc Med
1 Front Physiol
1 Int J Mol Sci
1 J Cardiothorac Vasc Anesth
1 J Cardiovasc Pharmacol
1 J Clin Med
1 J Heart Lung Transplant
1 Nat Commun
1 Pediatr Res
1 Perfusion
1 PLoS One
1 Pulm Circ
1 Respir Investig
1 Respir Med
1 Rev Esp Cardiol (Engl Ed)
1 RMD Open
1 Sci Transl Med
1 Semin Cardiothorac Vasc Anesth
1 Sleep Med
2 Ther Adv Respir Dis
1 Turkish J Nephrol
1 Zhonghua Nei Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

    When Bad and Worse Collide: Venous Thromboembolic Disease and Pulmonary Hypertension.
    Am J Cardiol. 2024 Jan 9:S0002-9149(23)00252.

    Am J Transplant

  2. TOSHIMA T, Rhu J, Yoon YI, Ito T, et al
    Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group.
    Am J Transplant. 2024;24:57-69.
    PubMed         Abstract available

    Animals (Basel)

  3. MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
    Right Ventricle Strain Assessed by 2-Dimensional Speckle Tracking Echocardiography (2D-STE) to Evaluate Pulmonary Hypertension in Dogs with Dirofilaria immitis.
    Animals (Basel). 2023;14:26.
    PubMed         Abstract available

    Basic Clin Pharmacol Toxicol

  4. CHE Y, Xia T, Liu H, Li C, et al
    Preparation of betaine injection and its therapeutic effect in pulmonary arterial hypertension.
    Basic Clin Pharmacol Toxicol. 2024;134:219-230.
    PubMed         Abstract available

    Biomed Pharmacother

  5. DE BIE FR, Regin Y, Dubois A, Scuglia M, et al
    Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic hernia.
    Biomed Pharmacother. 2024;170:115996.
    PubMed         Abstract available

    BMJ Case Rep

  6. GUPTA S, Mohta A, Thameem D
    Vasoreactive pulmonary artery hypertension in non-fibrotic hypersensitive pneumonitis.
    BMJ Case Rep. 2024;17:e255921.
    PubMed         Abstract available

    Cardiovasc Res

  7. ZHANG J, Xu C, Tang X, Sun S, et al
    Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through KLF4 deacetylation.
    Cardiovasc Res. 2024 Jan 10:cvae011. doi: 10.1093.
    PubMed         Abstract available


  8. FRANTZ RP, Swift AJ
    Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
    Chest. 2024;165:12-13.

  9. CELANT LR, Wessels JN, Marcus JT, Meijboom LJ, et al
    Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2024;165:181-191.
    PubMed         Abstract available


  10. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    PubMed         Abstract available

    Clin Genet

  11. BZDEGA K, Biela M, Deutsch GH, Kitzmiller JA, et al
    A novel non-recurrent CNV deletion involving TBX4 and leaving TBX2 intact causes congenital alveolar dysplasia.
    Clin Genet. 2024;105:190-195.
    PubMed         Abstract available

    Clin Nucl Med

  12. SZABARI MV, Ni C, Davila D, Viragh K, et al
    Pulmonary Arterial Tumor Embolism From Recurrent Metastatic Renal Cell Carcinoma on FDG PET/CT.
    Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004956.
    PubMed         Abstract available

    Clin Rheumatol

  13. HUO X, Zeng Z, Lin Y, Lin J, et al
    Clinical characteristics of systemic sclerosis patients with occupational silicosis.
    Clin Rheumatol. 2024;43:277-287.
    PubMed         Abstract available

    Cold Spring Harb Mol Case Stud

  14. TOWER DR, Day RW, Marrone T, Palmquist R, et al
    Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure.
    Cold Spring Harb Mol Case Stud. 2024;9:a006292.
    PubMed         Abstract available

    Commun Biol

  15. TOMITA S, Nakanishi N, Ogata T, Higuchi Y, et al
    The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
    Commun Biol. 2024;7:40.
    PubMed         Abstract available

    Comput Biol Med

  16. YU X, Qin W, Cai H, Ren C, et al
    Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking.
    Comput Biol Med. 2023;169:107863.
    PubMed         Abstract available


  17. SINGHI AK, Mohapatra SK, Biswas N, Bandyopadhyay KH, et al
    PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India.
    Cureus. 2023;15:e50996.
    PubMed         Abstract available

  18. ABDEEN AMZ, Alagha Z, Clark C, Al-Astal A, et al
    Paradoxical Worsening of Pulmonary Hypertension Following Closure of Arteriovenous Fistula: A Case Report and Literature Review.
    Cureus. 2023;15:e50064.
    PubMed         Abstract available

  19. SONAGLIONI A, Nicolosi GL, Rispoli GA, Lombardo M, et al
    Incidental Finding of Lipomatous Hypertrophy of the Right Atrial Free Wall in an Elderly Female With Severe Pulmonary Hypertension: Early Detection by Multimodality Imaging.
    Cureus. 2023;15:e50665.
    PubMed         Abstract available

    Curr Probl Cardiol

  20. MANSOOR M, Shahid S, Tariq S, Aziz A, et al
    Letter to Editor: Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension (PAH) Patients in Gansu China: An Observational Cohort Study.
    Curr Probl Cardiol. 2024;49:102133.

  21. SALAZAR AM, Panama G, Kim AG, Rayamajhi S, et al
    Clinical outcomes between direct oral anticoagulants versus vitamin K antagonists in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Curr Probl Cardiol. 2024;49:102377.
    PubMed         Abstract available

    ESC Heart Fail

  22. ZHANG A, Ding L, Zhang H, Mi L, et al
    Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter.
    ESC Heart Fail. 2024 Jan 10. doi: 10.1002/ehf2.14659.
    PubMed         Abstract available

    Eur Respir J

  23. PLUNKETT MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, et al
    The skeletal muscle metaboreflex: a novel driver of ventilation, dyspnoea and pulmonary haemodynamics during exercise in pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2300952.
    PubMed         Abstract available


  24. DESAI R, Gandhi Z, Shiza ST, Jain A, et al
    Prevalence and impact of tobacco use disorder on in-hospital mortality in patients hospitalized with non-group 1 pulmonary hypertension: a nationwide propensity score-matched analysis, 2019.
    EXCLI J. 2023;22:1200-1210.
    PubMed         Abstract available

    Expert Opin Pharmacother

  25. KULARATNE M, Boucly A, Savale L, Solinas S, et al
    Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
    Expert Opin Pharmacother. 2023;24:2101-2115.
    PubMed         Abstract available

    Front Cardiovasc Med

  26. HUANG J, Zhang W, Fu W, Le J, et al
    Noninvasive evaluation of pulmonary hypertension using the second heart sound parameters collected by a mobile cardiac acoustic monitoring system.
    Front Cardiovasc Med. 2023;10:1292647.
    PubMed         Abstract available

    Front Physiol

  27. SCHULZE KM, Horn AG, Weber RE, Behnke BJ, et al
    Pulmonary hypertension alters blood flow distribution and impairs the hyperemic response in the rat diaphragm.
    Front Physiol. 2023;14:1281715.
    PubMed         Abstract available

    Int J Mol Sci

  28. D'AGOSTINO A, Lanzafame LG, Buono L, Crisci G, et al
    Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;25:36.
    PubMed         Abstract available

    J Cardiothorac Vasc Anesth

  29. BRUCE MR, Frasco PE, Sell-Dottin KA, Cuevas CV, et al
    Days Alive and Out of the Hospital After Heart Transplantation: A Retrospective Cohort Study.
    J Cardiothorac Vasc Anesth. 2024;38:93-100.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  30. LI J, He X, Liu F, Zheng X, et al
    Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    J Cardiovasc Pharmacol. 2024;83:73-85.
    PubMed         Abstract available

    J Clin Med

  31. CONTRERAS J, Nussbaum J, Cangialosi P, Thapi S, et al
    Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review.
    J Clin Med. 2024;13:285.
    PubMed         Abstract available

    J Heart Lung Transplant

  32. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
    Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
    J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
    PubMed         Abstract available

    Nat Commun

  33. ULRICH A, Wu Y, Draisma H, Wharton J, et al
    Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
    Nat Commun. 2024;15:330.
    PubMed         Abstract available

    Pediatr Res

  34. OUELLET S, Drolet C, Morissette G, Pellerin A, et al
    Vasopressin in newborns with refractory acute pulmonary hypertension.
    Pediatr Res. 2024 Jan 11. doi: 10.1038/s41390-023-02995.
    PubMed         Abstract available


  35. IVANOV B, Krasivskyi I, Forster F, Gaisendrees C, et al
    Impact of pulmonary hypertension on short-term outcomes in patients undergoing surgical aortic valve replacement for severe aortic valve stenosis.
    Perfusion. 2024 Jan 11:2676591241227883. doi: 10.1177/02676591241227883.
    PubMed         Abstract available

    PLoS One

  36. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    PLoS One. 2024;19:e0296068.
    PubMed         Abstract available

    Pulm Circ

  37. SHLOBIN OA, Shen E, Wort SJ, Piccari L, et al
    Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
    Pulm Circ. 2024;14:e12310.
    PubMed         Abstract available

    Respir Investig

  38. SALAHUDDIN M, Shahid S, Tariq U, Aqeel M, et al
    Outcomes of patients with elevated pulmonary artery systolic pressure on echocardiography due to chronic lung diseases.
    Respir Investig. 2024;62:69-74.
    PubMed         Abstract available

    Respir Med

  39. AKSOY A, Kocakaya D, Demircioglu O, Cimsit NC, et al
    Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
    Respir Med. 2024;221:107481.
    PubMed         Abstract available

    Rev Esp Cardiol (Engl Ed)

  40. BRITO J, Pinto FJ, Placido R
    Chronic fibrothrombotic deposits: a cause or consequence of pulmonary hypertension?
    Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00015.

    RMD Open

  41. ALVAREZ TRONCOSO J, Soto Abanades C, Robles-Marhuenda A, Alcolea Batres S, et al
    Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
    RMD Open. 2024;10:e003674.
    PubMed         Abstract available

    Sci Transl Med

  42. TAI YY, Yu Q, Tang Y, Sun W, et al
    Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.
    Sci Transl Med. 2024;16:eadd2029.
    PubMed         Abstract available

    Semin Cardiothorac Vasc Anesth

  43. RAJKUMAR S, Jha AK, Parida S, Thangaswamy CR, et al
    Effect of Acute Vasodilator Testing Using Oxygen in Pulmonary Hypertension Due to Left Heart Disease.
    Semin Cardiothorac Vasc Anesth. 2024 Jan 10:10892532241227082.
    PubMed         Abstract available

    Sleep Med

  44. HUANG Z, Duan A, Zhao Z, Zhao Q, et al
    Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.
    Sleep Med. 2024;113:61-69.
    PubMed         Abstract available

    Ther Adv Respir Dis

  45. DONG S, Guo X, Wang H, Sun C, et al
    Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data.
    Ther Adv Respir Dis. 2024;18:17534666231223606.
    PubMed         Abstract available

  46. YANG Y, Li X, Wang P, Shu S, et al
    The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
    Ther Adv Respir Dis. 2024;18:17534666231224692.
    PubMed         Abstract available

    Turkish J Nephrol

  47. LENTINE KL, Levine DJ, Runo JR, Caliskan Y, et al
    Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive review.
    Turkish J Nephrol. 2024;33:8-26.
    PubMed         Abstract available

    Zhonghua Nei Ke Za Zhi

  48. ZHENG SW, Wang Z, Zhai ZG, Sun YH, et al
    [Progresses in pulmonary hypertension associated with left-sided heart failure].
    Zhonghua Nei Ke Za Zhi. 2024;63:113-120.

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.